USPTO serial 79308937
DEEPZEMA AI-AUGMENTED DRUG DISCOVERY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 24, 2022
- Examiner
- SEVERSON, JUSTIN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with DEEPZEMA AI-AUGMENTED DRUG DISCOVERY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cynthia A. Moyer
Cynthia A. Moyer Fredrikson & Byron, P.A.200 South Sixth StreetSuite 4000Minneapolis, MN 55402Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Medicine research; research of pharmaceuticals; drug discovery services; research of crude medicines; research of medicines; research service of pharmaceuticals; development of pharmaceuticals and drugs; clinical trial; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy in the field of testing, inspection, research of medical products; conducting early evaluations in the field of new pharmaceuticals; development of biotechnology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Innovo Therapeutics Inc.
- Other trademarks owned by Innovo Therapeutics Inc.
- Other trademarks owned by Innovo Therapeutics Inc.
- Other trademarks in Class 042
- Similar marks named DEEPZEMA AI-AUGMENTED DRUG DISCOVERY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 2, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 10, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 9, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 24, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 24, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 24, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 22, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 22, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 20, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 2, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 2, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 2, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 18, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 13, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 12, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 12, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 15, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 24, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 15, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 28, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 27, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 17, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 20, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 16, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 15, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |